Manuscripts.Contemporary Clinical Trials accepts for consideration manuscripts containing original material if neither
the article nor any part of its essential substance, tables, or figures has been or will be published or is currently submitted elsewhere
before appearing in Contemporary Clinical Trials. This restriction does not apply to abstracts or press reports published in
connection with scientific meetings.
Other Communications.Contemporary Clinical Trials invites Short Communications
(manuscripts of 1500 or fewer words, excepting references, tables and figures) and Letters to the Editor (500 or fewer words,
12 or fewer references) for possible publication.
Guidelines for Submission.
All articles should be submitted electronically
using the Elsevier Editorial System (EES). EES is a web-based system with full online submission, review and status update capabilities.
EES allows you to upload files directly from your computer.
You may access EES at http://ees.elsevier.com/cct/.
If you are using EES for the first time, you must register before
you submit a paper. To do so, please click on "Submit Paper," then
"Not Yet Registered," to begin the registration process.
Submission Categories & Reviewers: When submitting a manuscript
to Contemporary Clinical Trials, the author will need to assign it to one of the following major categories:
•Clinical
Trial Results • Special Interest Paper • Clinical Trial Management & Optimization • Patient Recruitment
• Patient Registries • Study Design, Statistical Design, Study Protocols
The author must suggest 5 peer reviewers
in the field for consideration by the editorial staff.
For each submission, submit (by FAX) a cover letter signed by all authors
and identify the person (with a complete address, telephone number, fax number and e-mail address) responsible for correspondence. State
in the letter that all authors have seen and approved the final manuscript.
Credit for authorship requires substantial contributions
to: (a) conception and design, or analysis and interpretation of data; and (b) the drafting of the article or critical revision for important
intellectual content.
Send this FAX to Beth Kazol, Managing Editor, 211 East Chicago Avenue, Suite 1450, Chicago, IL 60611, USA.
Tel: (312) 475-3633, Fax: (312)475 2692, E-mail: beth_kazol@iristrials.com.
Conflict of Interest. Authors of
research articles should disclose in the cover letter of the submission any financial arrangement they may have with a company whose
product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in
confidence while the paper is under review and will not influence the editorial decision. If the article is accepted for publication,
the editors will discuss with the authors the manner in which such information is to be communicated to the reader.
Title Page.
The title page should include the following information: the title of the paper; the name of each author, including first name; the institutional
affiliation (including city, state and country) of each author; the name and contact information (phone, fax, address, email) of the
person to whom reprint requests should be addressed; and any grant support that requires acknowledgment.
Abstract and Key Words.
On a separate page, provide an abstract of 300 or fewer words. Following the abstract, provide three to ten key words or short phrases.
References. Number references consecutively using Arabic numerals in brackets, e.g., [1, 2], as they are cited in the text.
For references first cited in tables or figure legends, number so they will be in sequence with references cited in the text. For references
with fewer than six authors, list all authors. For references with six or more authors, list the first three authors followed by "et
al."
Articles in Special Issues: Please ensure that the words 'this issue' are added (in the list and text) to any
references to other articles in this Special Issue.
Abbreviate journal names using abbreviations from the Index Medicus.
Examples:
[1] DuMouchel W. Bayesian meta-analysis. In: Berry D, ed. Statistical Methodology
in Pharmaceutical Sciences. New York:
Marcel Dekker, 1990.
[2] Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH. Biostatistics in Clinical Medicine.
3rd ed. New York:
McGraw-Hill, 1993.
[3] Snowdon C, Elbourne D, Garcia J. Zelen randomization: attitudes of parents participating in a neonatal clinical
trial. Control Clin Trials 1999;20:149-171.
The reference list can include articles that are "in press." However, verification that
the article has been accepted for publication must be obtained. The reference list cannot include personal communications, unpublished
data, or manuscripts either "in preparation" or "submitted for publication."
If essential, such material may be incorporated as appropriate
in the text (see "Permissions").
Tables. All tables must be cited in the text. Double-space tables. Number tables using Arabic
numerals sequentially in order of appearance, and place on separate, portrait-oriented pages. Put explanatory notes and other details
relating to the body of a table in footnotes identified by superscript,
lowercase letters.
Illustrations and Figures. All
illustrations and figures must be cited in the text. Number illustrations and figures using Arabic numerals sequentially in order of
appearance. Figures should be professionally designed. Glossy 5" X 7" photographs are requested. (Computer-generated figures produced
by a 300 dpi laser printer are also acceptable.) Symbols, lettering, and numbering must be clear and large enough to remain legible after
the figure has been reduced. On the back of each figure and illustration, write lightly in pencil the figure or illustration number,
the name of the first author, and an arrow indicating the top. Do not mount illustrations or figures on cardboard.
Include titles, figure
or illustration numbers, and legends on a separate sheet. The titles, figure or illustration numbers, and legends should not appear on
the figures and illustrations.
Acknowledgments. Prepare acknowledgments on a separate page. Obtain permission from all individuals
named.
Abbreviations. Except for units of measurement, abbreviations are discouraged. Consult Scientific Style and Format:
The CBE Manual for Authors, Editors, and Publishers (6th ed. New York: Cambridge University Press, 1994) for lists of standard abbreviations.
Define abbreviations and acronyms the first time they are used.
Drug Names. Generic names should generally be used. When proprietary
brands are used in research, include the brand name in parentheses to refer to drugs.
Permissions. Materials taken from other
sources must be accompanied by a written statement from both author and publisher giving permission to Contemporary Clinical Trials
for reproduction. For unpublished data and personal communications, obtain permission in writing from at least one author.
Review.
The editorial staff reviews all manuscripts. Two outside referees review all manuscripts accepted for peer review. The editorial staff
encourages authors to suggest names of possible reviewers, but reserves the right of final selection.
Proofs. One set of page
proofs in PDF format will be sent by e-mail to the corresponding Author (if we do not have an e-mail address then paper proofs will be
sent by post). Elsevier now sends PDF proofs which can be annotated for this you will need to download Adobe Reader version 7 (or higher)
available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will
accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/accrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query form) and return
to Elsevier in an e-mail. Please list you corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query form) on a printout of your proof and return by fax, or scan the pages and e-mail
or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor.
We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of
your corrections are send back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article
if no response is received.
Other information:
Publication schedule. Regular issues of Contemporary Clinical
Trials are published six times per year.
Reprints. The corresponding author, at no cost, will be provided with a PDF
file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
Journal Publishing
Agreement and Permissions
Upon acceptance of an article, authors will be asked to sign a 'Journal Publishing Agreement'
(for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of
the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers
may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions.
Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including
compilations and translations (please consult http://www.elsevier.com/permissions).
If excerpts from other copyrighted works
are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier
has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Funding
body agreements and policies
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier
journals to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about
existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Authors' rights
As
an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Language Services. Authors who require information about language editing and copyediting services pre- and post-submission
please visit http://www.elsevier.com/locate/languagepolishing or contact authorsupport@elsevier.com for more
information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors
through our services or in any advertising. For more information please refer to our Terms & Conditions http://www.elsevier.com/termsandconditions.
